for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Faes Farma acuerda con Novartis comercializar fármaco en España

MADRID, 16 jun (Reuters) - Faes Farma FAE.MC ha alcanzado un acuerdo con la suiza Novartis NOVN.VX para comercializar en España una molécula para el tratamiento de la enfermedad pulmonar obstructiva crónica (EPOC).

“Está previsto su lanzamiento en septiembre”, dijo el grupo en un comunicado enviado el miércoles por la tarde a la CNMV.

Breakingviews

Reuters Breakingviews is the world's leading source of agenda-setting financial insight. As the Reuters brand for financial commentary, we dissect the big business and economic stories as they break around the world every day. A global team of about 30 correspondents in New York, London, Hong Kong and other major cities provides expert analysis in real time.


Sign up for a free trial of our full service at https://www.breakingviews.com/trial and follow us on Twitter @Breakingviews and at www.breakingviews.com. All opinions expressed are those of the authors.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up